Latest news about bitcoin, ethereum, blockchain, mining, cryptocurrency prices and more
SAN FRANCISCO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), the nation’s leading provider …
Category:
News
-
-
-
BusinessGlobeNewswire
Acadia Healthcare (ACHC) Faces Class Action Lawsuit Over Patient Detention Practices – Hagens Berman
ACHC Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) …
-
RANCHO CORDOVA, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) — Five Star Bancorp (Nasdaq: FSBC) (“Five Star” …
-
BusinessGlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights …
-
BusinessGlobeNewswire
FSLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into First Solar, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, …
-
BusinessGlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Acadia Healthcare Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ACHC
NEW YORK, Oct. 26, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights …
-
BusinessGlobeNewswire
Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
First to demonstrate clinical benefit in patients with chronic inducible urticaria (CIndU) in large, randomized, placebo-controlled …
-
BusinessGlobeNewswire
Mulvihill Capital Management Inc. Announces Special Meeting of Mulvihill U.S. Health Care Enhanced Yield ETF
TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) — (TSX: XLVE) Mulvihill Capital Management Inc. (the “Manager”), …
-
BusinessGlobeNewswire
Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas
WARREN, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings …